Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Prognosis

Prognosis

Up to 60% of patients relapse after initial treatment. Single organ pancreatobiliary disease has the most favourable prognosis. IgG4-RD is associated with a higher all cause mortality than the general population (Huggett et al., 2014). 

SECOND UK IGG4-RD SYMPOSIUM

Friday 3rd March 2023

Programme

Abstract submission

Brochure

Speaker Biographies

Posters

Gallery

IgG4-RD

easl.PNG